ES452200A1 - Un procedimiento para la preparacion de nuevos derivados de pipendina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de pipendina.

Info

Publication number
ES452200A1
ES452200A1 ES452200A ES452200A ES452200A1 ES 452200 A1 ES452200 A1 ES 452200A1 ES 452200 A ES452200 A ES 452200A ES 452200 A ES452200 A ES 452200A ES 452200 A1 ES452200 A1 ES 452200A1
Authority
ES
Spain
Prior art keywords
benzazolylalkyl
piperidines
substituted
benzazolyalkyl
class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452200A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of ES452200A1 publication Critical patent/ES452200A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Pueden encontrarse algunas 1-(dialquilaminoalquil)-1,3-dihidro-2H-bencimidazol-2-onas, entre las que se encuentran las 1,3-dihidro-2H-bencimidazol-2-onas, que poseen propiedades antidepresivas y anticonvulsivas. Entre otras diferencias, los compuestos de esta invención difieren de los compuestos conocidos en la naturaleza del núcleo de piperidina 4-sustituida. Las nuevas 1-benzazolilalquil-piperidinas 4-sustituidas de esta invención pueden ser representadas estructuralmente por la fórmula: **(Fórmula)** y sus sales de adición de ácidos farmacéuticamente aceptables.
ES452200A 1975-10-08 1976-10-07 Un procedimiento para la preparacion de nuevos derivados de pipendina. Expired ES452200A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (1)

Publication Number Publication Date
ES452200A1 true ES452200A1 (es) 1978-01-16

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452200A Expired ES452200A1 (es) 1975-10-08 1976-10-07 Un procedimiento para la preparacion de nuevos derivados de pipendina.

Country Status (31)

Country Link
US (1) US4035369A (es)
JP (1) JPS5246082A (es)
AT (1) AT365185B (es)
AU (1) AU511834B2 (es)
BG (1) BG27542A3 (es)
CA (1) CA1085853A (es)
CH (1) CH630915A5 (es)
CS (1) CS225101B2 (es)
DE (1) DE2645125A1 (es)
DK (1) DK151801C (es)
EG (1) EG12969A (es)
ES (1) ES452200A1 (es)
FI (1) FI63228C (es)
FR (1) FR2346009A1 (es)
GB (1) GB1532546A (es)
GR (1) GR61672B (es)
HU (1) HU174927B (es)
IE (1) IE43951B1 (es)
IL (1) IL50631A (es)
IT (1) IT1069293B (es)
LU (1) LU75954A1 (es)
NL (1) NL7611085A (es)
NO (1) NO144926C (es)
NZ (1) NZ182134A (es)
PH (1) PH15417A (es)
PL (1) PL106815B1 (es)
PT (1) PT65688B (es)
RO (1) RO69904A (es)
SE (1) SE417610B (es)
SU (1) SU663306A3 (es)
YU (1) YU39976B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
ATE247114T1 (de) 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
WO2008035066A2 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
AU2022237901A1 (en) * 2021-03-19 2023-09-28 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (es) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (es) 1968-07-26 1969-07-04
US3635982A (en) * 1969-04-08 1972-01-18 American Home Prod Amino-substituted-quinoxalinyloxazolidines and -oxazines

Also Published As

Publication number Publication date
NL7611085A (nl) 1977-04-13
AU511834B2 (en) 1980-09-11
FR2346009B1 (es) 1978-12-22
CH630915A5 (de) 1982-07-15
PH15417A (en) 1983-01-07
DK151801C (da) 1988-06-06
AU1807876A (en) 1978-04-06
PL192890A1 (pl) 1978-03-28
RO69904A (fr) 1980-08-15
IL50631A0 (en) 1976-12-31
NO144926B (no) 1981-08-31
IT1069293B (it) 1985-03-25
DE2645125C2 (es) 1988-11-24
FR2346009A1 (fr) 1977-10-28
LU75954A1 (es) 1977-05-09
GB1532546A (en) 1978-11-15
FI63228C (fi) 1983-05-10
NZ182134A (en) 1979-01-11
US4035369A (en) 1977-07-12
SE7611137L (sv) 1977-04-09
NO763424L (es) 1977-04-13
PT65688A (en) 1976-11-01
ATA745276A (de) 1981-05-15
IE43951B1 (en) 1981-07-01
FI63228B (fi) 1983-01-31
JPS5246082A (en) 1977-04-12
PL106815B1 (pl) 1980-01-31
SE417610B (sv) 1981-03-30
DK452076A (da) 1977-04-09
HU174927B (hu) 1980-04-28
CA1085853A (en) 1980-09-16
GR61672B (en) 1978-12-05
CS225101B2 (en) 1984-02-13
SU663306A3 (ru) 1979-05-15
IE43951L (en) 1977-04-08
EG12969A (en) 1981-03-31
PT65688B (en) 1978-04-02
FI762865A (es) 1977-04-09
JPS6215553B2 (es) 1987-04-08
YU248076A (en) 1983-01-21
DE2645125A1 (de) 1977-04-21
BG27542A3 (en) 1979-11-12
AT365185B (de) 1981-12-28
DK151801B (da) 1988-01-04
IL50631A (en) 1980-02-29
YU39976B (en) 1985-06-30
NO144926C (no) 1981-12-09

Similar Documents

Publication Publication Date Title
MY102705A (en) Proline derivaties and related compounds.
NL7603960A (nl) Boorhamer.
ES449083A1 (es) Un procedimiento para la preparacion de un compuesto de aci-do 1-alquil (inferior)-5-aroilpirrol-2-acetico halogenado.
AU505281B2 (en) Drill chuck
ZA764322B (en) Novel 1-(benzazolyalkyl)piperidine derivatives
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
ES461641A1 (es) Un procedimiento para preparar nuevos derivados de bencimi- dazol.
ES438714A1 (es) Un procedimiento para la preparacion de un derivado de ben- cimidazolinona.
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
ES466483A1 (es) Un procedimiento para la preparacion de derivados de azol
KE3215A (en) Novel,1-(benzazolylalkyl)piperidine derivatives
AU502983B2 (en) Drill chuck
NL165392B (nl) Beitelhouder.
AU498067B2 (en) Drill chuck
ES462862A1 (es) Un procedimiento para preparar una composicion de aril-hi- drazonas con propiedades biocidas.
ES452736A1 (es) Un procedimiento para preparar compuestos de aroil-fenildi- deno y aroil-fenilnaftaleno.
ATA450476A (de) Schlaghammer, -meissel oder -bohrer
ES424946A1 (es) Procedimiento para la preparacion de derivados de imidazol.
ES421130A1 (es) Procedimiento para preparar derivados de ditiino (1,4) (2, 3-c) pirrol.
ES445073A1 (es) Procedimiento para preparar derivados de 5-nitrotiazolilimi-dazolidina.
ES446051A1 (es) Procedimiento para la preparacion de azabicicloalcanis y compuestos intermedios de los mismos.
ES449991A1 (es) Procedimiento para la preparacion de derivados de acido 7 (alfaamino-omega-(2,3-metilenodioxifenil y acilamido) cefa- losporanico.
ES449603A1 (es) Procedimiento para la preparacion de derivados de acido 6-(-amino-w-(3,4-metilenodioxifenil)acilamido) penicilanico.
ES437510A1 (es) Un procedimiento para la preparacion de compuestos de deca- hidroisoquinolina.
ES449604A1 (es) Procedimiento para la preparacion de derivados de acido 6-(-amino-w-2, 3-metilenodioxifenil)acilamido) penicilanico.